Company profile: PharmaJet
1.1 - Company Overview
Company description
- Provider of needle-free jet injection systems for fixed-dose intradermal, intramuscular, and subcutaneous vaccine delivery. Offerings include Tropis ID (0.1 ml intradermal), Stratis IM/SC (0.5 ml IM/SC with charging station), and platforms for nucleic acid, COVID-19 (e.g., ZyCoV-D), polio, and influenza (e.g., Afluria) vaccine delivery, enhancing cellular dispersion and immunogenicity and providing an alternative to needles.
Products and services
- Nucleic Acid Vaccine Delivery: Clinical-grade needle-free systems for nucleic acid vaccines that enhance cellular dispersion and immunogenicity during administration
- Stratis IM/SC: Modular needle-free system delivering 0.5 ml intramuscular and subcutaneous injections, featuring a hand-held device paired with a separate charging station for streamlined operation
- Tropis ID: Custom-engineered needle-free system for fixed 0.1 ml intradermal injections, using a spring-powered mechanism for rapid delivery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaJet
Hallux
HQ: United States
Website
- Description: Provider of a physician-applied topical terbinafine gel for treating onychomycosis. Hallux Subungual Gel (HSG) is applied directly onto the nail bed, utilizing the subungual space for targeted delivery to the infection site.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hallux company profile →
Milestone Scientific
HQ: United States
Website
- Description: Provider of computer-controlled injection technologies for medical and dental care, including the CompuFlo Epidural Instrument with visual/audio feedback to locate the epidural space; the STA Single Tooth Anesthesia system for precise dental delivery; DPS Dynamic Pressure Sensing and automated flow/pressure control for consistent injections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Milestone Scientific company profile →
Elutia
HQ: United States
Website
- Description: Provider of customized tissue products, including CanGaroo, an acellular envelope for securing implantable electronic devices to promote healthy tissue integration and wound healing; SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction with rapid integration and revascularization and a low inflammatory response; and CanGarooRM, a next-generation drug-eluting biomatrix for securing cardiac devices or neurostimulators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Elutia company profile →
Sensile Medical
HQ: Switzerland
Website
- Description: Provider of liquid drug delivery devices and platforms developed in Switzerland, offering safe, cost-efficient, customizable on- and off-body solutions—featuring reusable and disposable concepts—for subcutaneous administration of biologics and small molecules, including Gx SensAir, on-body and belt-worn infusors with adjustable flow and connectivity, an inhalation assessment platform, and the Gx Inbeneo autoinjector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensile Medical company profile →
Sancilio & Company
HQ: United States
Website
- Description: Provider of biopharmaceutical products and services, including cardiovascular and dental health offerings such as OCEAN BLUE PROFESSIONAL OMEGA-3 2100 and LUDENT; plus startup guidance, compound discovery and synthesis, FDA and EMA-compliant analytical support, dual-facility stability studies, formulation development, and FDA-guideline drug manufacturing across dosage forms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sancilio & Company company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaJet
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaJet
2.2 - Growth funds investing in similar companies to PharmaJet
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaJet
4.2 - Public trading comparable groups for PharmaJet
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →